表紙:幹細胞製造の北米市場-業界動向と2028年までの予測
市場調査レポート
商品コード
1029960

幹細胞製造の北米市場-業界動向と2028年までの予測

North America Stem Cell Manufacturing Market - Industry Trends and Forecast to 2028

出版日: | 発行: Data Bridge Market Research Private Limited | ページ情報: 英文 90 Pages | 納期: 3~5営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=115.72円
幹細胞製造の北米市場-業界動向と2028年までの予測
出版日: 2021年08月01日
発行: Data Bridge Market Research Private Limited
ページ情報: 英文 90 Pages
納期: 3~5営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

北米の幹細胞製造市場規模は、2021年から2028年にかけて、10.1%の大幅なCAGRで成長すると予測されています。

当レポートでは、北米の幹細胞製造市場について調査分析し、規制、PESTEL分析、ポーターズファイブフォース分析、促進要因、抑制要因、市場機会、課題、COVID-19の影響、製品別、アプリケーション別、エンドユーザー別、流通チャネル別、地域別市場情報、企業情勢、SWOT分析、企業プロファイルを提供しています。

目次

第1章 イントロダクション

第2章 市場セグメンテーション

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 北米の幹細胞製造市場:規制

  • 規制の枠組み:米国
  • 規制の枠組み:欧州
  • 規制の枠組み:インド
  • 規制の枠組み:日本

第6章 PESTEL分析

第7章 ポーターズファイブフォース分析

第8章 市場概要

  • 促進要因
    • 癌の有病率の増加
    • 研究開発への投資の増加
    • 幹細胞治療の採用の増加
    • ヘルスケア支出増による、バイオテクノロジー分野の成長
  • 抑制要因
    • 治療に関連する高コスト
    • 腫瘍治療のための代替利用の可能性
    • 幹細胞移植の副作用
  • 市場機会
    • パイプライン製品の存在
    • 主要プレーヤーによる戦略的イニシアチブ
    • 様々な国でのヘルスケアインフラの増大
    • 個別化医療への関心の高まり
  • 課題
    • 熟練した専門家の不足
    • 厳格な規制

第9章 北米の幹細胞製造市場:COVID-19の影響

  • 価格への影響
  • 需要への影響
  • 供給への影響
  • COVID-19間の市場プレーヤーによるイニシアチブ
  • 結論

第10章 北米の幹細胞製造市場:製品別

  • 概要
  • 消耗品とキット
    • 培地
    • 差別化キット
    • 幹細胞抗体アレイ
    • 識別キット
    • 幹細胞抗体パネル
    • 幹細胞プライマーペアパネル
    • 造血幹細胞拡張のためのサイトカインパネル
    • 血統枯渇抗体およびキット
    • その他
  • 幹細胞ライン
    • 人細胞システム
    • 齧歯細胞システム
  • 手段
    • バイオリアクターとインキュベーター
    • セルソーター
    • その他

第11章 北米の幹細胞製造市場:アプリケーション別

  • 概要
  • 調査アプリケーション
    • ライフサイエンス調査
    • 創薬と開発
  • 臨床アプリケーション
    • 同種幹細胞治療
    • 自家幹細胞治療
  • 細胞と組織のバンキング
  • その他

第12章 北米の幹細胞製造市場:エンドユーザー別

  • 概要
  • バイオテクノロジーおよび製薬企業
  • 調査機関および学術機関
  • 細胞バンクと組織バンク
  • 病院および外科センター
  • その他

第13章 北米の幹細胞製造市場:流通チャネル別

  • 概要
  • 直接販売
  • 第3者流通

第14章 北米の幹細胞製造市場: 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ

第15章 北米の幹細胞製造市場:企業情勢

  • 企業シェア分析:北米

第16章 SWOT分析

第17章 企業プロファイル

  • THERMO FISHER SCIENTIFIC INC.
  • TAKEDA PHARMACEUTICAL COMPANY LIMITED
  • MERCK KGAA
  • AMERICAN CRYOSYSTEM CORPORATION
  • ANTEROGEN.CO.,LTD.
  • ASTELLAS PHARMA INC.
  • BD
  • BIO-TECHNE
  • CATALENT, INC
  • DAIICHI SANKYO COMPANY, LIMITED
  • FUJIFILM CELLULAR DYNAMICS, INC.
  • MESOBLAST LTD
  • ORGANOGENESIS INC.
  • PROMOCELL GMBH
  • REPROCELL INC.
  • SARTORIUS AG
  • STEMCELL TECHNOLOGIES INC.
  • VERICEL CORPORATION
  • VIACYTE, INC.
  • VISTAGEN THERAPEUTICS, INC.

第18章 アンケート

第19章 関連レポート

図表

LIST OF TABLES

TABLE 1 BELOW PROVIDED ARE THE ALTERNATIVES FOR CANCER TREATMENT:

  • TABLE 2 TOTAL HEALTH SPENDING BY THE U.S. (2015-2016)
  • TABLE 3 NORTH AMERICA STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 4 NORTH AMERICA CONSUMABLES & KITS IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 5 NORTH AMERICA CONSUMABLES & KITS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 6 NORTH AMERICA STEM CELL LINES IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 7 NORTH AMERICA STEM CELL LINES IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 8 NORTH AMERICA HUMAN CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 9 NORTH AMERICA PRIMARY HUMAN CELLS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 10 NORTH AMERICA RODENT CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 11 NORTH AMERICA INSTRUMENTS IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 12 NORTH AMERICA INSTRUMENTS IN STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
  • TABLE 13 NORTH AMERICA STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 14 NORTH AMERICA RESEARCH APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 15 NORTH AMERICA RESEARCH APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 16 NORTH AMERICA CLINICAL APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 17 NORTH AMERICA CLINICAL APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 18 NORTH AMERICA ALLOGENIC STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 19 NORTH AMERICA AUTOLOGOUS STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 20 NORTH AMERICA CELL & TISSUE BANKING IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 21 NORTH AMERICA OTHERS IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 22 NORTH AMERICA STEM CELL MANUFACTURING MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 23 NORTH AMERICA BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 24 NORTH AMERICA RESEARCH INSTITUTES AND ACADEMIC INSTITUTES IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 25 NORTH AMERICA CELL BANKS & TISSUE BANKS IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 26 NORTH AMERICA HOSPITALS & SURGICAL CENTERS IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 27 NORTH AMERICA OTHERS IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 28 NORTH AMERICA STEM CELL MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 29 NORTH AMERICA DIRECT SALES IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 30 NORTH AMERICA THIRD PARTY DISTRIBUTORS IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 31 NORTH AMERICA STEM CELL MANUFACTURING MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
  • TABLE 32 NORTH AMERICA STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 33 NORTH AMERICA CONSUMABLES & KITS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 34 NORTH AMERICA STEM CELL LINES IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 35 NORTH AMERICA HUMAN CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 36 NORTH AMERICA PRIMARY HUMAN CELLS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 37 NORTH AMERICA RODENT CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 38 NORTH AMERICA INSTRUMENTS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 39 NORTH AMERICA STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 40 NORTH AMERICA RESEARCH APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 41 NORTH AMERICA CLINICAL APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 42 NORTH AMERICA ALLOGENIC STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 43 NORTH AMERICA AUTOLOGOUS STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 44 NORTH AMERICA STEM CELL MANUFACTURING MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 45 NORTH AMERICA STEM CELL MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 46 U.S. STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 47 U.S. CONSUMABLES & KITS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 48 U.S. STEM CELL LINES IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 49 U.S. HUMAN CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 50 U.S. PRIMARY HUMAN CELLS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 51 U.S. RODENT CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 52 U.S. INSTRUMENTS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 53 U.S. STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 54 U.S. RESEARCH APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 55 U.S. CLINICAL APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 56 U.S. ALLOGENIC STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 57 U.S. AUTOLOGOUS STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 58 U.S. STEM CELL MANUFACTURING MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 59 U.S. STEM CELL MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 60 CANADA STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 61 CANADA CONSUMABLES & KITS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 62 CANADA STEM CELL LINES IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 63 CANADA HUMAN CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 64 CANADA PRIMARY HUMAN CELLS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 65 CANADA RODENT CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 66 CANADA INSTRUMENTS IN STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 67 CANADA STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 68 CANADA RESEARCH APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 69 CANADA CLINICAL APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 70 CANADA ALLOGENIC STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 71 CANADA AUTOLOGOUS STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 72 CANADA STEM CELL MANUFACTURING MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 73 CANADA STEM CELL MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 74 MEXICO STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 75 MEXICO CONSUMABLES & KITS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 76 MEXICO STEM CELL LINES IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 77 MEXICO HUMAN CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 78 MEXICO PRIMARY HUMAN CELLS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 79 MEXICO RODENT CELL SYSTEMS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 80 MEXICO INSTRUMENTS IN STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 81 MEXICO STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 82 MEXICO RESEARCH APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 83 MEXICO CLINICAL APPLICATIONS IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 84 MEXICO ALLOGENIC STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 85 MEXICO AUTOLOGOUS STEM CELL THERAPY IN STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 86 MEXICO STEM CELL MANUFACTURING MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 87 MEXICO STEM CELL MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1 NORTH AMERICA STEM CELL MANUFACTURING MARKET: SEGMENTATION
  • FIGURE 2 NORTH AMERICA STEM CELL MANUFACTURING MARKET: DATA TRIANGULATION
  • FIGURE 3 NORTH AMERICA STEM CELL MANUFACTURING MARKET: DROC ANALYSIS
  • FIGURE 4 NORTH AMERICA STEM CELL MANUFACTURING MARKET : NORTH AMERICA VS REGIONAL MARKET ANALYSIS
  • FIGURE 5 NORTH AMERICA STEM CELL MANUFACTURING MARKET : COMPANY RESEARCH ANALYSIS
  • FIGURE 6 NORTH AMERICA STEM CELL MANUFACTURING MARKET: INTERVIEW DEMOGRAPHICS
  • FIGURE 7 NORTH AMERICA STEM CELL MANUFACTURING MARKET: DBMR MARKET POSITION GRID
  • FIGURE 8 NORTH AMERICA STEM CELL MANUFACTURING MARKET: MARKET APPLICATION COVERAGE GRID
  • FIGURE 9 NORTH AMERICA STEM CELL MANUFACTURING MARKET: VENDOR SHARE ANALYSIS
  • FIGURE 10 NORTH AMERICA STEM CELL MANUFACTURING MARKET: SEGMENTATION
  • FIGURE 11 INCREASING ADOPTION OF STEM CELL THERAPY IS EXPECTED TO DRIVE THE NORTH AMERICA STEM CELL MANUFACTURING MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
  • FIGURE 12 CONSUMABLES & KITS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA STEM CELL MANUFACTURING MARKET IN 2021 & 2028
  • FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF NORTH AMERICA STEM CELL MANUFACTURING MARKET
  • FIGURE 14 NEW CANCER CASES WORLDWIDE IN 2018
  • FIGURE 15 NORTH AMERICA STEM CELL MANUFACTURING MARKET, BY PRODUCTS, 2020
  • FIGURE 16 NORTH AMERICA STEM CELL MANUFACTURING MARKET: BY PRODUCTS, 2021-2028 (USD MILLION )
  • FIGURE 17 NORTH AMERICA STEM CELL MANUFACTURING MARKET: BY PRODUCTS, CAGR (2021-2028)
  • FIGURE 18 NORTH AMERICA STEM CELL MANUFACTURING MARKET: BY PRODUCTS, LIFELINE CURVE
  • FIGURE 19 NORTH AMERICA STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2020
  • FIGURE 20 NORTH AMERICA STEM CELL MANUFACTURING MARKET: BY APPLICATION, 2021-2028 (USD MILLION )
  • FIGURE 21 NORTH AMERICA STEM CELL MANUFACTURING MARKET: BY APPLICATION, CAGR (2021-2028)
  • FIGURE 22 NORTH AMERICA STEM CELL MANUFACTURING MARKET: BY APPLICATION, LIFELINE CURVE
  • FIGURE 23 NORTH AMERICA STEM CELL MANUFACTURING MARKET, BY END USER, 2020
  • FIGURE 24 NORTH AMERICA STEM CELL MANUFACTURING MARKET: BY END USER, 2021-2028 (USD MILLION )
  • FIGURE 25 NORTH AMERICA STEM CELL MANUFACTURING MARKET: BY END USER, CAGR (2021-2028)
  • FIGURE 26 NORTH AMERICA STEM CELL MANUFACTURING MARKET: BY END USER, LIFELINE CURVE
  • FIGURE 27 NORTH AMERICA STEM CELL MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2020
  • FIGURE 28 NORTH AMERICA STEM CELL MANUFACTURING MARKET: BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION )
  • FIGURE 29 NORTH AMERICA STEM CELL MANUFACTURING MARKET: BY DISTRIBUTION CHANNEL, CAGR (2021-2028)
  • FIGURE 30 NORTH AMERICA STEM CELL MANUFACTURING MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
  • FIGURE 31 NORTH AMERICA STEM CELL MANUFACTURING MARKET: SNAPSHOT (2020)
  • FIGURE 32 NORTH AMERICA STEM CELL MANUFACTURING MARKET: BY COUNTRY (2020)
  • FIGURE 33 NORTH AMERICA STEM CELL MANUFACTURING MARKET: BY COUNTRY (2021 & 2028)
  • FIGURE 34 NORTH AMERICA STEM CELL MANUFACTURING MARKET: BY COUNTRY (2020 & 2028)
  • FIGURE 35 NORTH AMERICA STEM CELL MANUFACTURING MARKET: BY PRODUCTS (2021-2028)
  • FIGURE 36 NORTH AMERICA STEM CELL MANUFACTURING MARKET: COMPANY SHARE 2020 (%)
目次

North America stem cell manufacturing market is projected to register a substantial CAGR of 10.1% in the forecast period of 2021 to 2028. The new market report contains data for the historic year 2019, the base year of calculation is 2020, and the forecast period is 2021 to 2028.

Market Segmentation:

North America Stem Cell Manufacturing Market, By Products (Stem Cell Lines, Instruments, Consumables & Kits), Application (Research Applications, Clinical Applications, Cell and Tissue Banking and Others),End User (Biotechnology & Pharmaceutical Companies, Research Institutes and Academic Institutes, Cell Banks and Tissue Banks, Hospital & Surgical Centers and Others), Distribution Channel (Direct Sales and Third Party Distributor), Country (U.S., Canada & Mexico) Industry Trends and Forecast to 2028

Some of the major factors contributing to the growth of the North America stem cell manufacturing market are:

  • Growing adoption of stem cell transplant
  • Strategic Initiatives by key players
  • Large number of pipeline products

Market Players:

The key market players for North America stem cell manufacturing market are listed below:

  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • BD
  • Organogenesis Inc.
  • Vericel Corporation
  • ANTEROGEN. CO., LTD.
  • VistaGen Therapeutics, Inc.
  • FUJIFILM Cellular Dynamics, Inc.
  • American CryoSystem Corporation
  • PromoCell GmbH
  • Sartorius AG, ViaCyte, Inc.
  • STEM CELL Technologies, Inc.
  • Takeda Pharmaceutical Company Limited
  • DAIICHI SANKYO COMPANY, LIMITED
  • Bio-Techne
  • REPROCELL Inc.
  • Catalent, Inc
  • Mesoblast Ltd
  • Astellas Pharma Inc.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 OVERVIEW OF NORTH AMERICA STEM CELL MANUFACTURING MARKET
  • 1.4 LIMITATIONS
  • 1.5 MARKETS COVERED

2 MARKET SEGMENTATION

  • 2.1 MARKETS COVERED
  • 2.2 GEOGRAPHICAL SCOPE
  • 2.3 YEARS CONSIDERED FOR THE STUDY
  • 2.4 CURRENCY AND PRICING
  • 2.5 DBMR TRIPOD DATA VALIDATION MODEL
  • 2.6 MULTIVARIATE MODELLING
  • 2.7 PRODUCTS LIFELINE CURVE
  • 2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
  • 2.9 DBMR MARKET POSITION GRID
  • 2.10 MARKET APPLICATION COVERAGE GRID
  • 2.11 VENDOR SHARE ANALYSIS
  • 2.12 SECONDARY SOURCES
  • 2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 NORTH AMERICA STEM CELL MANUFACTURING MARKET: REGULATIONS

  • 5.1 REGULATORY FRAMEWORK IN THE UNITED STATES
  • 5.2 REGULATORY FRAMEWORK IN EUROPE
  • 5.3 REGULATORY FRAMEWORK IN INDIA
  • 5.4 REGULATORY FRAMEWORK IN JAPAN

6 PESTEL ANALYSIS

7 PORTERS FIVE FORCES

8 MARKET OVERVIEW

  • 8.1 DRIVERS
    • 8.1.1 INCREASING PREVALENCE OF CANCER
    • 8.1.2 INCREASE INVESTMENT IN R & D
    • 8.1.3 INCREASING ADOPTION OF STEM CELL THERAPY
    • 8.1.4 GROWING BIOTECHNOLOGY SECTOR, ALONG WITH RISING HEALTHCARE EXPENDITURE
  • 8.2 RESTRAINTS
    • 8.2.1 HIGH COST ASSOCIATED WITH THERAPIES
    • 8.2.2 AVAILABILITY OF ALTERNATIVES FOR TUMOR TREATMENT
    • 8.2.3 ADVERSE EFFECTS OF STEM CELL TRANSPLANT
  • 8.3 OPPORTUNITIES
    • 8.3.1 PRESENCE OF PIPELINE PRODUCTS
    • 8.3.2 STRATEGIC INITIATIVES BY MARKET PLAYERS
    • 8.3.3 RISING HEALTHCARE INFRASTRUCTURE BY VARIOUS COUNTRIES
    • 8.3.4 INCREASING INTEREST FOR PERSONALIZED MEDICINE
  • 8.4 CHALLENGES
    • 8.4.1 LACK OF SKILLED PROFESSIONALS
    • 8.4.2 STRINGENT REGULATIONS

9 IMPACT OF COVID-19 ON NORTH AMERICA STEM CELL MANUFACTURING MARKET

  • 9.1 IMPACT ON PRICE
  • 9.2 IMPACT ON DEMAND
  • 9.3 IMPACT ON SUPPLY
  • 9.4 KEY INITIATIVES BY MARKET PLAYER DURING COVID-19
  • 9.5 CONCLUSION

10 NORTH AMERICA STEM CELL MANUFACTURING MARKET, BY PRODUCTS

  • 10.1 OVERVIEW
  • 10.2 CONSUMABLES & KITS
    • 10.2.1 CULTURE MEDIA
    • 10.2.2 DIFFERENTIATION KITS
    • 10.2.3 STEM CELL ANTIBODY ARRAYS
    • 10.2.4 IDENTIFICATION KITS
    • 10.2.5 STEM CELL ANTIBODY PANELS
    • 10.2.6 STEM CELL PRIMER PAIR PANELS
    • 10.2.7 CYTOKINE PANELS FOR HEMATOPOIETIC STEM CELL EXPANSION
    • 10.2.8 LINEAGE DEPLETION ANTIBODIES & KITS
    • 10.2.9 OTHERS
  • 10.3 STEM CELL LINES
    • 10.3.1 HUMAN CELL SYSTEMS
      • 10.3.1.1 INDUCED PLURIPOTENT EMBRYONIC STEM CELLS
      • 10.3.1.2 MESENCHYMAL STEM CELLS
      • 10.3.1.3 PRIMARY HUMAN CELLS
        • 10.3.1.3.1 FIBROBLAST
        • 10.3.1.3.2 EPITHELIAL
        • 10.3.1.3.3 ENDOTHELIAL
      • 10.3.1.4 HEMATOPOIETIC STEM CELLS
      • 10.3.1.5 NEURAL STEM CELLS
      • 10.3.1.6 CARDIAC STEM CELLS
      • 10.3.1.7 PANCREATIC STEM CELLS
      • 10.3.1.8 OTHERS
    • 10.3.2 RODENT CELL SYSTEMS
      • 10.3.2.1 PLURIPOTENT MOUSE ES CELLS
      • 10.3.2.2 MOUSE EMBRYO CULTURE
      • 10.3.2.3 PMEFS
      • 10.3.2.4 MULTIPOTENT RODENT STEM CELLS
      • 10.3.2.5 MESENCHYMAL STEM CELLS
      • 10.3.2.6 NEURAL STEM CELLS
      • 10.3.2.7 OTHERS
  • 10.4 INSTRUMENTS
    • 10.4.1 BIOREACTORS & INCUBATORS
    • 10.4.2 CELL SORTERS
    • 10.4.3 OTHERS

11 NORTH AMERICA STEM CELL MANUFACTURING MARKET, BY APPLICATION

  • 11.1 OVERVIEW
  • 11.2 RESEARCH APPLICATIONS
    • 11.2.1 LIFE SCIENCE RESEARCH
    • 11.2.2 DRUG DISCOVERY AND DEVELOPMENT
  • 11.3 CLINICAL APPLICATIONS
    • 11.3.1 ALLOGENIC STEM CELL THERAPY
      • 11.3.1.1 SURGERIES
      • 11.3.1.2 MUSCULOSKELETAL DISORDERS
      • 11.3.1.3 WOUNDS AND INJURIES
      • 11.3.1.4 ACUTE GRAFT-VERSUS-HOST DISEASE (AGVHD)
      • 11.3.1.5 OTHERS
    • 11.3.2 AUTOLOGOUS STEM CELL THERAPY
      • 11.3.2.1 WOUNDS & INJURIES
      • 11.3.2.2 CARDIOVASCULAR DISEASES
      • 11.3.2.3 GASTROINTESTINAL DISEASES
      • 11.3.2.4 OTHERS
  • 11.4 CELL & TISSUE BANKING
  • 11.5 OTHERS

12 NORTH AMERICA STEM CELL MANUFACTURING MARKET, BY END USER

  • 12.1 OVERVIEW
  • 12.2 BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES
  • 12.3 RESEARCH INSTITUTES AND ACADEMIC INSTITUTES
  • 12.4 CELL BANKS & TISSUE BANKS
  • 12.5 HOSPITALS & SURGICAL CENTERS
  • 12.6 OTHERS

13 NORTH AMERICA STEM CELL MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL

  • 13.1 OVERVIEW
  • 13.2 DIRECT SALES
  • 13.3 THIRD PARTY DISTRIBUTORS

14 NORTH AMERICA STEM CELL MANUFACTURING MARKET, BY REGION

  • 14.1 NORTH AMERICA
    • 14.1.1 U.S.
    • 14.1.2 CANADA
    • 14.1.3 MEXICO

15 NORTH AMERICA STEM CELL MANUFACTURING MARKET: COMPANY LANDSCAPE

  • 15.1 COMPANY SHARE ANALYSIS: NORTH AMERICA

16 SWOT ANALYSIS

17 COMPANY PROFILE

  • 17.1 THERMO FISHER SCIENTIFIC INC.
    • 17.1.1 COMPANY SNAPSHOT
    • 17.1.2 REVENUE ANALYSIS
    • 17.1.3 COMPANY SHARE ANALYSIS
    • 17.1.4 PRODUCT PORTFOLIO
    • 17.1.5 RECENT DEVELOPMENT
  • 17.2 TAKEDA PHARMACEUTICAL COMPANY LIMITED
    • 17.2.1 COMPANY SNAPSHOT
    • 17.2.2 REVENUE ANALYSIS
    • 17.2.3 COMPANY SHARE ANALYSIS
    • 17.2.4 PRODUCT PORTFOLIO
    • 17.2.5 RECENT DEVELOPMENTS
  • 17.3 MERCK KGAA
    • 17.3.1 COMPANY SNAPSHOT
    • 17.3.2 REVENUE ANALYSIS
    • 17.3.3 COMPANY SHARE ANALYSIS
    • 17.3.4 PRODUCT PORTFOLIO
    • 17.3.5 RECENT DEVELOPMENTS
  • 17.4 AMERICAN CRYOSYSTEM CORPORATION
    • 17.4.1 COMPANY SNAPSHOT
    • 17.4.2 REVENUE ANALYSIS
    • 17.4.3 PRODUCT PORTFOLIO
    • 17.4.4 RECENT DEVELOPMENTS
  • 17.5 ANTEROGEN.CO.,LTD.
    • 17.5.1 COMPANY SNAPSHOT
    • 17.5.2 REVENUE ANALYSIS
    • 17.5.3 PRODUCT PORTFOLIO
    • 17.5.4 RECENT DEVELOPMENT
  • 17.6 ASTELLAS PHARMA INC.
    • 17.6.1 COMPANY SNAPSHOT
    • 17.6.2 REVENUE ANALYSIS
    • 17.6.3 PRODUCT PORTFOLIO
    • 17.6.4 RECENT DEVELOPMENT
  • 17.7 BD
    • 17.7.1 COMPANY SNAPSHOT
    • 17.7.2 REVENUE ANALYSIS
    • 17.7.3 COMPANY SHARE ANALYSIS
    • 17.7.4 PRODUCT PORTFOLIO
    • 17.7.5 RECENT DEVELOPMENT
  • 17.8 BIO-TECHNE
    • 17.8.1 COMPANY SNAPSHOT
    • 17.8.2 REVENUE ANALYSIS
    • 17.8.3 PRODUCT PORTFOLIO
    • 17.8.4 RECENT DEVELOPMENTS
  • 17.9 CATALENT, INC
    • 17.9.1 COMPANY SNAPSHOT
    • 17.9.2 REVENUE ANALYSIS
    • 17.9.3 PRODUCT PORTFOLIO
    • 17.9.4 RECENT DEVELOPMENTS
  • 17.10 DAIICHI SANKYO COMPANY, LIMITED
    • 17.10.1 COMPANY SNAPSHOT
    • 17.10.2 REVENUE ANALYSIS
    • 17.10.3 PRODUCT PORTFOLIO
    • 17.10.4 RECENT DEVELOPMENT
  • 17.11 FUJIFILM CELLULAR DYNAMICS, INC.
    • 17.11.1 COMPANY SNAPSHOT
    • 17.11.2 COMPANY SHARE ANALYSIS
    • 17.11.3 PRODUCT PORTFOLIO
    • 17.11.4 RECENT DEVELOPMENTS
  • 17.12 MESOBLAST LTD
    • 17.12.1 COMPANY SNAPSHOT
    • 17.12.2 REVENUE ANALYSIS
    • 17.12.3 PRODUCT PORTFOLIO
    • 17.12.4 RECENT DEVELOPMENT
  • 17.13 ORGANOGENESIS INC.
    • 17.13.1 COMPANY SNAPSHOT
    • 17.13.2 PRODUCT PORTFOLIO
    • 17.13.3 RECENT DEVELOPMENT
  • 17.14 PROMOCELL GMBH
    • 17.14.1 COMPANY SNAPSHOT
    • 17.14.2 PRODUCT PORTFOLIO
    • 17.14.3 RECENT DEVELOPMENTS
  • 17.15 REPROCELL INC.
    • 17.15.1 COMPANY SNAPSHOT
    • 17.15.2 REVENUE ANALYSIS
    • 17.15.3 PRODUCT PORTFOLIO
    • 17.15.4 RECENT DEVELOPMENTS
  • 17.16 SARTORIUS AG
    • 17.16.1 COMPANY SNAPSHOT
    • 17.16.2 REVENUE ANALYSIS
    • 17.16.3 PRODUCT PORTFOLIO
    • 17.16.4 RECENT DEVELOPMENTS
  • 17.17 STEMCELL TECHNOLOGIES INC.
    • 17.17.1 COMPANY SNAPSHOT
    • 17.17.2 PRODUCT PORTFOLIO
    • 17.17.3 RECENT DEVELOPMENTS
  • 17.18 VERICEL CORPORATION
    • 17.18.1 COMPANY SNAPSHOT
    • 17.18.2 REVENUE ANALYSIS
    • 17.18.3 PRODUCT PORTFOLIO
    • 17.18.4 RECENT DEVELOPMENTS
  • 17.19 VIACYTE, INC.
    • 17.19.1 COMPANY SNAPSHOT
    • 17.19.2 PRODUCT PORTFOLIO
    • 17.19.3 RECENT DEVELOPMENTS
  • 17.20 VISTAGEN THERAPEUTICS, INC.
    • 17.20.1 COMPANY SNAPSHOT
    • 17.20.2 PRODUCT PORTFOLIO
    • 17.20.3 RECENT DEVELOPMENT

18 QUESTIONNAIRE

19 RELATED REPORTS